Growth differentiation factor 15: an emerging diagnostic biomarker of liver fibrosis in chronic hepatitis C patients.

Egypt Liver J · 2021 · PMC7814860 · PMID 34777864

Europe PMC DOI

hedged sentences

0.0100

closest p · 0.2× alpha

0.0100

boldest claim

The sentences

highly significantp < 0.01actually significant

Results Our results revealed a highly significant statistical rise in GDF-15 levels among studied chronic HCV patients with liver fibrosis when compared to the control group ( p < 0.01).

also in 132,142 other papers

borderline significantno p-value reported

Borderline significant difference was revealed as regards GDF-15 ( p value 0.075) among the three patients’ subgroups using Kruskal-Wallis test but by doing post hook test using Wilcoxon rank sum test between each two groups, levels of GDF-15 were significantly higher in subgroup III patients when compared with subgroup I patients.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.